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The aim of this study is to establish a simple, objective blastocyst grading system using women’s age 
and embryo developmental speed to predict clinical pregnancy following single vitrified-warmed 
blastocyst transfer (SVBT) by 6-year retrospective cohort study in a private infertility center. 
A total of 7,341 SVBT cycles divided into 2006-2011 (6,046 cycles) and 2012 cohort (1,295 cycles) 
were included. Clinical (CPR), ongoing pregnancy (OPR) and delivery rates (DR) were stratified by 
women’s age (<35, 35-37, 38-39, 40-41, 42-45 years) and time to blastocyst expansion (<120, 
120-129, 130-139, 140-149, >149 hours) as embryo developmental speed. In all the age groups, CPR, 
OPR, and DR decreased as the embryo developmental speed decreased (P < 0.0001). A simple 5-grade 
score based on women’s age and embryo developmental speed was determined by actual clinical 
pregnancy rates observed in the 2006-2011 cohort. Subsequently the novel grading score was 
validated in the 2012 cohort (1295 cycles) finding an excellent association. In conclusion, in the 
present study we established a novel blastocyst grading system using women’s age and embryo 
developmental speed as objective parameters. 
 
Keywords: minimal ovarian stimulation, single embryo transfer, blastocyst culture, outcome 
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Introduction 
Single blastocyst transfer is increasingly used during in-vitro fertilization treatment to prevent 
multiple conceptions. When several embryos are available after prolonged embryo culture a thorough 
evaluation of each blastocyst is needed to identify those with the highest implantation potential. Since 
its inception the blastocyst grading system developed by Gardner et al based on the degree of 
blastocyst expansion and the morphology of the inner cell mass and trophectoderm cells was widely 
used in various institutions around the world (Gardner and Schoolcraft, 1999). Subsequently the 
association between these morphological parameters of the blastocyst and pregnancy rates has been 
evaluated in many studies (Gardner et al., 2000; Matsuura et al., 2010; Hill et al., 2013). However the 
morphological evaluation of blastocysts is inherently subjective, greatly observer-dependent and there 
is still an ongoing debate on which morphological parameters have the highest prognostic value. 
Therefore it is needed to further improve existing blastocyst grading systems by incorporating more 
objective and reproducible variables. 
The developmental speed of the embryo is an important variable to consider while ascertaining 
its quality. For cleavage-stage embryos it has been reported that, the implantation rate is higher for 
embryos that cleave earlier (Lee et al., 2012). Similarly studies involving blastocyst transfer 
procedures have examined differences in implantation rates between blastocysts developing up until 
day 5 versus day 6 (Stehlik et al., 2005; Liebermann et al., 2006; Sunkara et al., 2010). These reports 
did not provide details on the degree of expansion of the transferred blastocysts and their results 
varied considerably. In a previous study of our group, we have noticed that the greater the degree of 
expansion of the blastocyst, the higher was its implantation potential (Okimura et al., 2009). Therefore 
by examining those blastocysts with a uniform degree of expansion the association between embryo 
developmental speed to blastocyst and the success rates may be examined more accurately. The aim of 
the present study was to analyze success rates following single vitrified-warmed blastocyst transfer 
according to women’s age and embryo developmental speed and to establish a novel blastocyst 
grading system that could help to predict outcome following single vitrified blastocyst transfer. 
 
Materials and methods 
Patients and study design 
 
The present retrospective study was reviewed and approved by the independent Institutional 
Review Board of Kato Ladies Clinic, Tokyo (IRB approval number: 13-20, approved 12 September 
2013). A written informed consent was also obtained from all patients undergoing IVF treatment at 
our centre which informs them that de-indentified data could be used for retrospective analysis. A 
total of 5,948 patients undergoing 7,341 single vitrified-warmed blastocyst transfer (SVBT) cycles 
who fulfilled the below inclusion criteria were included in this retrospective analysis: (a) women’s age 
≤45 years, (b) patients undergoing SVBT with a 175-184 µm sized blastocyst showing a uniform 
degree of expansion, and (c) follow-up data on pregnancy outcome was available. Cycles resulting in 
monozygotic twin pregnancies and ectopic pregnancies were excluded. At our centre the blastocyst 
transfer strategy was routinely indicated in case of tubal factor infertility (tubal obstruction, 
hydrosalpinx, or a history of extrauterine pregnancy) and following previous failed cycles with single 
cleavage-stage embryo transfers and constituted a large part of treatments preformed in our center 
(Kato et al., 2012).  
In the first part of the analysis clinical pregnancy rates (CPR) were analyzed in 5 subgroups that 
were divided before vitrification, according to five women’s age (≤34, 35–37, 38–39, 40–41, and 
42–45 years) and five blastocyst growth rate categories (≤119, 120–129, 130–139, 140–149, and ≥150 
hours). A simple grading system (grades A to E corresponded to a CPR of ≥54, 44-54, 34-43, 24-34 
and <24%, respectively) was established based on actual clinical pregnancy rates observed in the first 
half of the cohort (6046 cycles performed between 2006-2011). Subsequently the predictive value of 
the above grading system was evaluated in the second half of the cohort (1295 cycles performed 
during 2012). Additionally, ongoing pregnancy and delivery rates for grade were also calculated in 
each cohort. 
  
Minimal ovarian stimulation, oocyte retrieval and fertilization procedures 
 
All patients underwent a clomiphene-based minimal ovarian stimulation protocol or drug-free 
natural cycle IVF treatment (Teramoto et al., 2007; Kato et al., 2012). Oocyte retrieval was performed 
without any anesthesia, using a fine 21-22 G needle (Kitazato, Japan). Follicular flushing was not 
used during oocyte retrieval. Conventional insemination was performed approximately 3 h after 
retrieval, and intracytoplasmic sperm injection (ICSI) was performed 5h after retrieval. P1/cleavage 
stage medium (Irvine Scientific, USA) or human tubal fluid (HTF; Irvine Scientific, USA) with 10% 
serum substitute supplement (SSS; Irvine Scientific, USA) was used as the culture medium after 
insemination. 
 
Embryo culture, blastocyst monitoring and vitrification 
 
Fertilization assessment was performed 16–20 h after insemination. Normally fertilized zygotes 
with 2 pronuclei were cultured individually in a drop of 20 μL of Quinn’s Advantage Protein Plus 
cleavage medium (SAGE, USA) from days 1–3. The embryos were transferred to Quinn’s Advantage 
Protein Plus blastocyst medium (SAGE, USA) on day 3 and cultured until day 5 to 7. All embryos 
were cultured at 37°C under the gas phase of 5% O2, 5% CO2 and 90% N2 with 100 % humidity in 
water jacket small multigas incubators or dry desktop incubators (Astec, Japan). 
As mentioned previously only those patients having a blastocyst with an inner diameter between 
175–184 μm showing a uniform degree of blastocoel expansion were included in the present study. As 
per center protocol in order to closely monitor their development between days 5 to 7 embryos were 
checked routinely twice to four times daily. The first observation was usually performed at 08:00 h 
and if the embryo has already reached the blastocyst stage its size was checked every three hours until 
17:00 h. If the embryo did not reach the blastocyst stage yet it was checked again 6 hours later at 
14:00 h and three hours afterwards at 17:00 h. If the embryos still did not reach the blastocyst with an 
inner diameter of >160 μm or hatching blastocyst , it was checked again the following day at 08:00 h. 
Blastocyst checking was only performed by well-trained senior embryologists and each observation 
was finished within one minute. Measurements of the blastocyst’s inner diameter were performed 
with an inverted microscope (IX-71, Olympus, Japan or TE2000-U, Nikon, Japan) and corresponding 
imaging software (CellSens, Olympus, Japan or OCTAX EyeWare™, OCTAX Microscience GmbH, 
Germany).  
Those blastocysts reaching an inner diameter of >160 μm or hatching blastocyst by day 5 to 6 
were vitrified immediately according to the Cryotop method (Kuwayama, 2007). If the developing 
embryo did not fulfill the desired criteria it was cultured further until a maximum of up to day 7. For 
day 7 blastocysts vitrification criteria were blastocysts reaching an inner diameter of >180 μm or 
hatching. If the embryo did not fulfill the above criteria by day 7 it was discarded. The time interval 
from insemination to blastocyst vitrification was measured in hours (rounded up or down at a 0.5h 
interval) to quantify the embryo developmental speed until blastocyst stage.  
 
Post-warming embryo culture, embryo transfer procedure and outcome measures 
 During the study period only single embryo transfers were performed in our center and an exclusive 
SET policy was strictly observed. Therefore, the cohort was analyzed on a per cycle basis. Single 
vitrified-warmed blastocysts were transferred on day 4.5 to 5 after ovulation during a spontaneous 
natural cycle, as mentioned in our previous report (Kato et al., 2012). After warming surviving 
blastocysts were cultured for 30 minutes to 2 hours until blastocoel re-expansion was confirmed. Only 
those blastocysts were transferred where the blastocoel size remained the same or increased as 
compared with before vitrification state. Degenerating blastocysts were discarded. 
The embryo transfer procedure was performed under vaginal ultrasonography guidance using a 
specially designed soft silicone inner catheter (Kitazato, Japan) by placing a single blastocyst, 
suspended in minimal medium volume, in the upper part of the uterine cavity. Dydrogesterone (30 
mg/day orally, Daiichi-Sankyo, Japan) was routinely administered during the early luteal phase after 
the transfer procedure. Moreover, intramuscular (125mg/5days, Fuji Pharma, Japan) or intravaginal 
(25 or 50mg/day, preparation in-house) progesterone was also administered until the 9th week of 
pregnancy in cases where endogenous progesterone production from the placenta was found to be 
insufficient. During the first trimester pregnancies were followed weekly by hormonal measurements 
and ultrasound until approximately 9 weeks of ongoing gestation, at which point patients were 
referred to their treating obstetrician for subsequent care.  
Main outcome measures were clinical pregnancy rate (with a confirmed gestational sac at 6-7 
weeks of pregnancy), ongoing pregnancy rate (a confirmed fetal heart beat at 9 weeks of pregnancy) 
and delivery rate (live birth at ≥22 weeks of pregnancy) per embryo transfer procedure. Pregnancy 
outcomes were ascertained by a written patient questionnaire and/or the treating obstetrician. Nominal 
variables were analyzed by the Fisher’s exact test or the Cochran-Armitage test for trend as 




Table 1 shows observed clinical pregnancy rates following single vitrified-warmed blastocyst 
transfer in the 2006-2011 cohort stratified by women’s age and blastocyst growth rate. Grades were 
established arbitrarily in 10% intervals corresponding to a CPR of ≥54, 44-53.9, 34-43.9, 24-33.9 and 
<24% for grades A to E, respectively. In a similar way Table 2 represents the ongoing pregnancy and 
delivery rates in the same 2006-2011 cohort. For all outcome variables pregnancy rates were 
significantly different (p < 0.0001) between groups and decreased progressively with increasing 
women’s age and increased time needed for blastocyst expansion. Table 3 shows observed CPR, OPR 
and DR in the 2006-2011 cohort stratified by grades A to E. The CPR, OPR and DR differed 
significantly among the grades (p < 0.05 for all variables). Table 4 represents a comparison of clinical 
pregnancy rates stratified by grades A to E in the 2006-2011 and 2012 cohort. There were no 
significant differences in these outcomes between subgroups the two cohorts confirming a good 




The present study showed that clinical pregnancy rates following vitrified blastocyst transfer 
could be accurately predicted using objective parameters only, such as women’s age and embryo 
developmental speed. This implies that more complicated morphological grading variables are not an 
obligatory part of a valid blastocyst grading system. This new grading system developed in the 
2006-2011 cohort showed good association with outcomes observed in the 2012 cohort. Furthermore 
the novel grading system might also be useful in predicting more robust outcomes such as ongoing 
pregnancy and delivery rates.  
Several previous studies have compared pregnancy rates according to the number of days 
required to reach the blastocyst stage (Stehlik et al., 2005; Liebermann et al., 2006; Sunkara et al., 
2010). However, in our unique cohort of single vitrified embryo transfers the association between 
embryo developmental speed and implantation potential could be analyzed even more accurately, 
because all the patients in the present study invariably underwent single blastocyst transfer 
(eliminating multiple embryo transfer as a confounder), a standard SVBT protocol was used (embryo 
transfer at day 4.5–5 after post-ovulation) and the degree of blastocyst expansion was similar for all 
included cycles. 
The speed at which the embryo has developed to the blastocyst stage seemed to be a highly 
important parameter in our novel blastocyst grading system. Morphological evaluation of blastocysts 
may yield ambiguous and varying results, depending on institutions and embryologists involved. It is 
inherently a more subjective process, especially when compared with the simpler and more 
standardized morphological evaluation criteria used for cleavage-stage embryos. In contrast, our new 
grading system could yield more accurate results of blastocyst evaluation because it is based on 
objective parameters, whereby subjective variations during its application can be largely avoided. In 
the present study, the relationship between the morphology of the blastocyst inner cell 
mass/trophectoderm and the blastocyst growth rate (mean±SD) in the cohort 2006-2011 was as 
follows: grade AA: 118.2 ± 5.2 h; grades AB-BB: 119.5 ± 6.5 h and grades BC-CC: 134.1 ± 12.1 h. 
This suggests that blastocysts showing adequate morphological characteristics might also have a 
higher developmental speed. This implies that a simple evaluation based on objective developmental 
speed may provide similar results to an accurate but more time-consuming morphological evaluation. 
However, this study did not compare timing of blastocyst expansion with blastocyst morphology as 
predictors of pregnancy outcome. Therefore, further studies are required to analyze the correlation 
between our novel evaluation methods and blastocyst morphology. 
In the present study, cycles were also evaluated based on the woman’s age. It has been already 
reported that the pregnancy rate using blastocyst transfer reduces progressively with increasing patient 
age (Goto et al., 2011). In a previous retrospective study, low blastocyst formation rate was also 
observed in advanced age group (Kato et al., 2012). According to the guidelines of the Japan Society 
of Obstetrics and Gynecology (the Japan Society of Obstetrics and Gynecology, 2006), donor eggs 
cannot be used for in-vitro fertilization even for advanced maternal aged patients in Japan, which 
underlines the importance of considering women’s age while evaluating blastocysts. 
Our grading system was developed in a large cohort where all patients underwent minimal 
ovarian stimulation or natural cycle IVF. In most cases of minimal ovarian stimulation and especially 
in natural cycle IVF treatment, there is only a single (if any) blastocyst available for embryo transfer. 
Therefore, there are few opportunities for blastocyst selection for transfer. However, this novel 
grading system might also be useful in the different setting of conventional ovarian stimulation where 
multiple embryos could be selected. Moreover while designing this novel, more objective blastocyst 
grading system we have also attempted to ensure at the same time efficient prediction and simplicity, 
whereby patients could easily understand the proposed grading. Similar to Gardner’s classification 
(Gardner and Schoolcraft, 1999), our grading system can be easily understood by patients; thus, the 
unrealistic expectations of older patients can be prevented and worry and concern amongst younger 
patients can be mitigated. Additionally, an even more accurate prediction of the success rates might be 
possible by combining this grading system with the classical Gardner's classification. 
The time of sperm penetration into the oocyte may vary depending on the fertilization method 
used. A limitation of the current study is that we did not evaluate any effect of the insemination 
method used (conventional in vitro fertilization versus ICSI). Similarly the measurement of embryo 
developmental speed was performed using multiple daily observations at discrete time points avoiding 
the use of expensive time-lapse technology. In future studies data from presumably more precise 
time-lapse observations could be incorporated to enhance the accuracy of our proposed blastocyst 
grading system. 
In conclusion, in the present study we established a novel blastocyst grading system using 
women’s age and blastocyst growth rate as objective parameters. This blastocyst grading system 
might be superior to previous grading systems because it is easy to implement and it could avoid 
institution- and observer-related variations. Although a retrospective validation suggested a good 
predictive value of the novel grading system it should be evaluated in a future, prospective study. 
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Table 1: Clinical pregnancy rates of the 2006-2011 cohort in subgroups stratified by women’s age and 
time required for blastocyst expansion after insemination. 
Age(years) 
Time required for blastocyst expansion after insemination (hours) 
pa 
<120 120-129 130-139 140-149 >149 
<35 y.  
66.1%(240 / 363)  64.5%(147 / 228)  52.6%(72 / 137)  36.6%(127 / 347)  35.3%(6 / 17)  
<0.0001 
 A  A B  C C   
35-37 y 
61.2%(249 / 407)  59.4%(151 / 254)  47.7%(74 / 155)  38.2%(181 / 474)  35.0%(7 / 20)  
<0.0001 
A A B C C 
38-39 y  
55.6%(178 / 320)  57.0%(130 / 228)  41.2%(61 / 148)  32.9%(136 / 413)  26.3%(5 / 19)  
<0.0001 
A A C D D 
40-41 y  
47.4%(145 / 306)  45.5%(101 / 222)  36.1%(44 / 122)  25.5%(123 / 482)  10.7%(3 / 28)  
<0.0001 
B B C D E 
42-45 y  
35.8%(112 / 313)  26.3%(62 / 236)  15.6%(25 / 160)  16.8%(105 / 626)  4.8%(1 / 21)  
<0.0001 
C D E E E 
 
In each cell the upper portion indicates the observed CPR and the lower portion indicates the 
attributed grade (grades A to E correspond to a CPR of ≥54, 44-54, 34-43, 24-34 and <24%, 
respectively). aCochrane-Armitage test for trend.
Table 2: Ongoing pregnancy and delivery rates of the 2006-2011 cohort in subgroups stratified by 
women’s age and time to required for blastocyst expansion after insemination. 
  Time to required for blastocyst expansion after insemination (h) 
pa 
  Age(y) <120 120-129 130-139 140-149 >149 
OPR 
<35 62.8% (228 / 363)  61.8% (141 / 228)  49.6% (68 / 137)  32.9% (114 / 347)  35.3% (6 / 17)  <0.0001 
35-37 55.0% (224 / 407)  54.3% (138 / 254)  41.9% (65 / 155)  32.9% (156 / 474)  30.0% (6 / 20)  <0.0001 
38-39 50.6% (162 / 320)  50.4% (115 / 228)  32.4% (48 / 148)  24.9% (103 / 413)  10.5% (2 / 19)  <0.0001 
40-41 40.8% (125 / 306)  38.3% (85 / 222)  27.9% (34 / 122)  20.7% (100 / 482)  7.1% (2 / 28)  <0.0001 
42-45 26.5% (83 / 313)  16.1% (38 / 236)  12.5% (20 / 160)  11.8% (74 / 626)  4.8% (1 / 21)  <0.0001 
DR 
<35 57.3% (208 / 363)  50.4% (115 / 228)  43.1% (59 / 137)  27.7% (96 / 347)  35.3% (6 / 17)  <0.0001 
35-37 44.7% (182 / 407)  48.4% (123 / 254)  30.3% (47 / 155)  27.4% (130 / 474)  20.0% (4 / 20)  <0.0001 
38-39 40.3% (129 / 320) 42.1% (96 / 228)  23.6% (35 / 148)  19.1% (79 / 413)  10.5% (2 / 19)  <0.0001 
40-41 27.8% (85 / 306)  25.2% (56 / 222)  18.0% (22 / 122)  15.1% (73 / 482)  7.1% (2 / 28)  <0.0001 
42-45 16.6% (52 / 313)  11.0% (26 / 236)  8.8% (14 / 160)  7.8% (49 / 626)  0.0% (0 / 21)  <0.0001 
aCochrane-Armitage test for trend. 
Table 3: Clinical (CPR), ongoing pregnancy (OPR) and delivery rates (DR) stratified by grades A to 
E in the 2006-2011 cohort. 
A significant difference was found in the rates among the grades (P < 0.05). 
Grades A B C D E 
Vitrified blastocyst transfers 1800 820 1441 1150 835 
CPR 60.8% (1095) 47.8% (392) 37.3% (538) 28.3% (326) 16.0% (134) 
OPR 56.0% (1008) 41.8% (343) 31.0% (447) 21.1% (243) 11.6% (97) 
DR 47.4% (853) 30.1% (247) 23.9% (345) 15.7% (180) 7.8% (65) 
Table 4: Comparison of clinical pregnancy rates according to grades A to E in the 2006-2011 and 
2012 cohorts. 
 2006–2011 2012 
Grade A 60.8% (1095/1800) 64.9% (251/387) 
Grade B 47.8% (392/820) 50.5% (97/192) 
Grade C 37.3% (538/1441) 34.1% (104/305) 
Grade D 28.3% (326/1150) 30.7% (69/225) 
Grade E 16.0% (134/835) 12.9% (24/186) 
No significant between-group differences were found. 
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